X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1682) 1682
propylamines - therapeutic use (1419) 1419
male (1168) 1168
female (909) 909
atomoxetine hydrochloride (724) 724
adult (626) 626
index medicus (601) 601
attention deficit disorder with hyperactivity - drug therapy (555) 555
middle aged (553) 553
animals (513) 513
child (453) 453
propylamines - pharmacology (449) 449
pharmacology & pharmacy (445) 445
adolescent (429) 429
psychiatry (386) 386
adrenergic uptake inhibitors - therapeutic use (372) 372
aged (356) 356
propylamines - adverse effects (348) 348
atomoxetine (322) 322
adhd (279) 279
clinical trials as topic (268) 268
children (251) 251
rats (248) 248
methylphenidate (241) 241
attention-deficit hyperactivity disorder (237) 237
treatment outcome (233) 233
deficit hyperactivity disorder (231) 231
double-blind method (230) 230
attention-deficit/hyperactivity disorder (227) 227
dose-response relationship, drug (227) 227
propylamines - administration & dosage (224) 224
central nervous system stimulants - therapeutic use (221) 221
neurosciences (211) 211
mexiletine - therapeutic use (207) 207
arrhythmias, cardiac - drug therapy (203) 203
drug therapy (187) 187
time factors (187) 187
methylphenidate - therapeutic use (186) 186
adolescents (178) 178
pediatrics (176) 176
propylamines (158) 158
adrenergic uptake inhibitors - adverse effects (155) 155
electrocardiography (145) 145
double-blind (142) 142
blood pressure - drug effects (133) 133
attention deficit disorder (132) 132
heart rate - drug effects (130) 130
amino alcohols - therapeutic use (126) 126
antidepressive agents - therapeutic use (118) 118
clinical neurology (118) 118
mice (113) 113
attention deficit disorder with hyperactivity - diagnosis (112) 112
adrenergic beta-antagonists - therapeutic use (109) 109
attention deficit hyperactivity disorder (109) 109
attention deficit disorder with hyperactivity - psychology (106) 106
psychiatric status rating scales (99) 99
drug therapy, combination (95) 95
adrenergic uptake inhibitors - pharmacology (94) 94
propylamines - chemistry (94) 94
hyperactivity (93) 93
administration, oral (92) 92
adults (87) 87
comorbidity (86) 86
placebos (80) 80
research (80) 80
tachycardia - drug therapy (80) 80
analysis (79) 79
central nervous system stimulants - adverse effects (78) 78
acetanilides - therapeutic use (77) 77
adrenergic uptake inhibitors - administration & dosage (76) 76
depression - drug therapy (76) 76
rats, sprague-dawley (76) 76
dopamine (75) 75
psychopharmacology (75) 75
care and treatment (74) 74
drug administration schedule (74) 74
child, preschool (72) 72
drug evaluation (72) 72
mexiletine - adverse effects (72) 72
hemodynamics - drug effects (71) 71
norepinephrine (71) 71
attention deficit disorder with hyperactivity - epidemiology (70) 70
phenethylamines (69) 69
psychology, developmental (69) 69
deficit/hyperactivity disorder (67) 67
tiapamil hydrochloride (67) 67
medicine & public health (66) 66
article (65) 65
kinetics (65) 65
prefrontal cortex (64) 64
deficit-hyperactivity disorder (63) 63
disease models, animal (63) 63
stimulants (63) 63
depressive disorder - drug therapy (62) 62
symptoms (62) 62
mexiletine - administration & dosage (61) 61
pharmacotherapy (61) 61
drugs (60) 60
severity of illness index (59) 59
clinical trials (57) 57
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1695) 1695
German (138) 138
French (62) 62
Italian (57) 57
Russian (40) 40
Spanish (32) 32
Polish (20) 20
Portuguese (18) 18
Japanese (17) 17
Czech (6) 6
Danish (4) 4
Romanian (4) 4
Swedish (4) 4
Chinese (3) 3
Hungarian (3) 3
Finnish (2) 2
Hebrew (2) 2
Norwegian (2) 2
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biological Psychiatry, ISSN 0006-3223, 2011, Volume 69, Issue 12, pp. e89 - e99
Journal Article
Psychopharmacology, ISSN 0033-3158, 2012, Volume 219, Issue 2, pp. 313 - 326
High levels of impulsivity are a core symptom of psychiatric disorders such as ADHD, mania, personality disorders and drug addiction. The effectiveness of... 
Econometric and Statistical Methods: General | Geneeskunde (GENK) | Bescherming en bevordering van de menselijke gezondheid | Medical sciences | Geneeskunde(GENK) | Neurosciences | Impulsivity | Biomedicine | Dopamine | Serotonin | Delayed reward | Pharmacology/Toxicology | Psychiatry | Noradrenaline | Five-choice serial reaction time task | PSYCHIATRY | GLOBAL 5-HT DEPLETION | DEFICIT-HYPERACTIVITY DISORDER | TERM ATOMOXETINE TREATMENT | NEUROSCIENCES | REACTION-TIME-TASK | PREFRONTAL CORTEX | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | RESPONSE-INHIBITION | NUCLEUS-ACCUMBENS CORE | NOREPINEPHRINE TRANSPORTER | PHARMACOLOGY & PHARMACY | D-AMPHETAMINE | Citalopram - pharmacology | Dopamine Uptake Inhibitors - therapeutic use | Male | Dose-Response Relationship, Drug | Time Factors | Reaction Time - drug effects | Atomoxetine Hydrochloride | Serial Learning - drug effects | Animals, Outbred Strains | Choice Behavior - drug effects | Adrenergic Uptake Inhibitors - therapeutic use | Dopamine Uptake Inhibitors - pharmacology | Amphetamine - therapeutic use | Amphetamine - pharmacology | Serotonin Uptake Inhibitors - therapeutic use | Rats | Piperazines - therapeutic use | Piperazines - pharmacology | Animals | Propylamines - therapeutic use | Adrenergic Uptake Inhibitors - pharmacology | Citalopram - therapeutic use | Impulsive Behavior - drug therapy | Propylamines - pharmacology | Serotonin Uptake Inhibitors - pharmacology | Antidepressants | Mental illness | Neurotransmitters | Inhibitor drugs | Response time | Animal behavior | Rodents | Psychopharmacology | Drug abuse | Drug addiction | Mental disorders | Attention deficit hyperactivity disorder | impulsive behavior | Drug delivery | Personality | Reaction time task | Intertrial interval | Amphetamine | Affective disorders | Reinforcement | Norepinephrine | citalopram | Neurotransmission | monoamines | Original Investigation
Journal Article
Psychopharmacology, ISSN 0033-3158, 1/2012, Volume 219, Issue 2, pp. 341 - 352
Impulsivity is associated with a number of psychiatric disorders, most notably attention deficit/hyperactivity disorder (ADHD). Drugs that augment... 
Neurosciences | Impulsivity | Sumanirole | Dopamine | Guanfacine | Quinpirole | GBR-12909 | Biomedicine | Atomoxetine | Pharmacology/Toxicology | Psychiatry | Noradrenaline | Five-choice serial reaction time task | Methylphenidate | TRAIT IMPULSIVITY | PSYCHIATRY | DEFICIT HYPERACTIVITY DISORDER | NEUROSCIENCES | REACTION-TIME-TASK | PREFRONTAL CORTEX | NUCLEUS-ACCUMBENS | DEFICIT/HYPERACTIVITY DISORDER | D2 RECEPTORS | MESSENGER-RNA | TERMINAL AUTORECEPTORS | PHARMACOLOGY & PHARMACY | Dopamine Agonists - therapeutic use | Adrenergic Agonists - pharmacology | Adrenergic Agonists - therapeutic use | Male | Reaction Time - drug effects | Atomoxetine Hydrochloride | Attention - drug effects | Serial Learning - drug effects | Animals, Outbred Strains | Benzimidazoles - therapeutic use | Dopamine Agonists - pharmacology | Choice Behavior - drug effects | Guanfacine - pharmacology | Rats | Guanfacine - therapeutic use | Methylphenidate - pharmacology | Piperazines - therapeutic use | Quinpirole - therapeutic use | Piperazines - pharmacology | Animals | Propylamines - therapeutic use | Methylphenidate - therapeutic use | Benzimidazoles - pharmacology | Impulsive Behavior - drug therapy | Propylamines - pharmacology | Quinpirole - pharmacology | Health aspects | Mental illness | Attention deficit disorder | Psychotropic drugs | Response time | Animal behavior | Psychopharmacology | Rodents | Drugs | Mental disorders | Attention deficit hyperactivity disorder | impulsive behavior | Attention | Dopamine D3 receptors | Catecholamines | Reaction time task | quinpirole | Adrenergic receptors | Norepinephrine | Dopamine D2 receptors | Dopamine receptors | Original Investigation
Journal Article
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, ISSN 0277-0008, 06/2009, Volume 29, Issue 6, pp. 656 - 679
Attention‐deficit‐hyperactivity disorder (ADHD) is a common neuropsychiatric disorder that impairs social, academic, and occupational functioning in children,... 
ADHD | methylphenidate | comorbidity | amphetamine | neurobiology | adult | atomoxetine | attention‐deficit‐hyperactivity disorder | pediatric | Amphetamine | Atomoxetine | Attention-deficit-hyperactivity disorder | Comorbidity | Neurobiology | Adult | Pediatric | Methylphenidate | SUBSTANCE USE DISORDERS | attention-deficit-hyperactivity disorder | FOLLOW-UP | RANDOMIZED CONTROLLED-TRIAL | STIMULANT TREATMENT | DEFICIT/HYPERACTIVITY DISORDER | MIXED AMPHETAMINE SALTS | PEDIATRIC BIPOLAR DISORDER | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | DOPAMINE TRANSPORTER GENE | LISDEXAMFETAMINE DIMESYLATE | United States - epidemiology | Prevalence | Follow-Up Studies | Conduct Disorder - drug therapy | Humans | Antidepressive Agents, Second-Generation - therapeutic use | Case-Control Studies | Central Nervous System Stimulants - therapeutic use | Central Nervous System Stimulants - adverse effects | Time Factors | Atomoxetine Hydrochloride | Attention Deficit Disorder with Hyperactivity - diagnosis | Child | Prescriptions | Bupropion - therapeutic use | Juvenile Delinquency | Adrenergic Uptake Inhibitors - therapeutic use | Amphetamine - therapeutic use | Treatment Outcome | Amphetamine - adverse effects | Methylphenidate - adverse effects | Attention Deficit Disorder with Hyperactivity - drug therapy | Propylamines - therapeutic use | Adolescent | Methylphenidate - therapeutic use | Attention Deficit Disorder with Hyperactivity - etiology | Patient Compliance | Substance-Related Disorders - drug therapy | Longitudinal Studies | Attention Deficit Disorder with Hyperactivity - epidemiology | Index Medicus
Journal Article
Neuropharmacology, ISSN 0028-3908, 2009, Volume 57, Issue 7, pp. 608 - 618
Results from techniques, especially intracerebral microdialysis in freely-moving rats, have provided insights into potential mechanisms responsible for the... 
ADHD | Amphetamine | Microdialysis | Spontaneously hypertensive rat | Lisdexamfetamine | Guanfacine | Vyvanse | Methylphenidate | ATTENTION-DEFICIT/HYPERACTIVITY-DISORDER | SPONTANEOUSLY HYPERTENSIVE-RATS | DEFICIT HYPERACTIVITY DISORDER | SALTS EXTENDED-RELEASE | NEUROSCIENCES | BIOGENIC-AMINE UPTAKE | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | ANIMAL-MODEL | LISDEXAMFETAMINE DIMESYLATE | D-AMPHETAMINE | FILM-COATED TABLETS | Central Nervous System Stimulants - pharmacology | Catecholamines - metabolism | Stereoisomerism | Humans | Dopamine Agents - therapeutic use | Brain - metabolism | Dopamine Agents - adverse effects | Attention Deficit Disorder with Hyperactivity - metabolism | Central Nervous System Stimulants - therapeutic use | Central Nervous System Stimulants - adverse effects | Dopamine Agents - pharmacology | Atomoxetine Hydrochloride | Adrenergic Uptake Inhibitors - adverse effects | Adrenergic Uptake Inhibitors - therapeutic use | Amphetamine - therapeutic use | Amphetamine - pharmacology | Methylphenidate - pharmacology | Amphetamine - adverse effects | Methylphenidate - adverse effects | Attention Deficit Disorder with Hyperactivity - drug therapy | Brain - drug effects | Animals | Propylamines - therapeutic use | Substance-Related Disorders - prevention & control | Methylphenidate - therapeutic use | Adrenergic Uptake Inhibitors - pharmacology | Propylamines - pharmacology | Propylamines - adverse effects | Drugs | Monoamine oxidase | Liability (Law) | Neurons | Attention-deficit hyperactivity disorder | Dextroamphetamine | Noradrenaline | Consulting services
Journal Article
Journal of the American Academy of Child & Adolescent Psychiatry, ISSN 0890-8567, 2007, Volume 46, Issue 12, pp. 1532 - 1572
ABSTRACT Systematic research and practice guidelines addressing preschool psychopharmacological treatment in very young children are limited, despite evidence... 
Pediatrics | Psychiatry | treatment | psychopharmacology | preschool | Preschool | Psychopharmacology | Treatment | POSTTRAUMATIC-STRESS-DISORDER | MEDICATION ALGORITHM PROJECT | PSYCHIATRY | DEFICIT HYPERACTIVITY DISORDER | PSYCHOLOGY, DEVELOPMENTAL | PERVASIVE DEVELOPMENTAL DISORDERS | OBSESSIVE-COMPULSIVE DISORDER | SEROTONIN REUPTAKE INHIBITORS | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | ABUSED PRESCHOOL-CHILDREN | COGNITIVE-BEHAVIORAL THERAPY | PEDIATRICS | PLACEBO-CONTROLLED TRIAL | Brain | Child Behavior | Behavior Disorders | Mental Disorders | Drug Therapy | Young Children | Pharmacology | Child Development | Psychopharmacology - standards | Humans | Child Psychiatry - standards | Child, Preschool | Attention Deficit Disorder with Hyperactivity - drug therapy | Drug Prescriptions - standards | Antidepressive Agents - therapeutic use | Mental Disorders - psychology | Algorithms | Amphetamines - therapeutic use | Central Nervous System Stimulants - therapeutic use | Propylamines - therapeutic use | Risperidone - therapeutic use | Antipsychotic Agents - therapeutic use | Mental Disorders - drug therapy | Atomoxetine Hydrochloride | Methylphenidate - therapeutic use | Psychopharmacology - trends | Mental Disorders - diagnosis | Psychological aspects | Care and treatment | Research | Preschool children | Child psychopathology | Child psychology | Mental disorders | Clinical psychology | Medical treatment
Journal Article